Centauri Health Solutions, Inc. (“Centauri”), a rapidly expanding healthcare technology and services provider, has secured a significant investment from Abry Partners (“Abry”), a leading North American private equity firm specializing in sector-focused investments. This strategic move, announced on January 9, 2020, sees Abry Partners acquire a majority stake in Centauri, positioning the healthcare innovator for accelerated growth and market leadership. This partnership underscores Abry Partners’ commitment to investing in companies that are not only demonstrating exceptional growth but also making a tangible difference in the healthcare landscape.
[ hình ảnh về logo Centauri Health Solutions, nếu có trong bài gốc ]
Abry Partners’ investment is specifically designed to empower Centauri to aggressively pursue key growth initiatives. These include accelerating the pace of product development to stay ahead of the curve in the dynamic healthcare technology sector, expanding sales and marketing operations to reach a wider client base, and strategically pursuing acquisitions to broaden its service offerings and market presence. For Abry Partners, this investment in Centauri aligns perfectly with their strategy of backing high-growth companies within their core industry verticals, particularly in the burgeoning healthcare IT space.
Adam Miller, co-founder and CEO of Centauri Health Solutions, expressed enthusiasm about the collaboration: “As we celebrate a year of unprecedented success, we are thrilled to welcome Abry Partners as our new lead investor. The team at Abry Partners, alongside our existing investors Silversmith Capital Partners (“Silversmith”) and SV Health Investors (“SV Health”), shares our belief in Centauri’s strategic vision and the positive impact our solutions have on both patients and health plan members. With the backing of Abry Partners, we are ideally positioned to accelerate our growth trajectory and enhance the suite of innovative technology and services we deliver to hospitals and health plans across the nation.” This statement highlights the synergistic alignment between Centauri’s ambitions and Abry Partners’ investment philosophy.
[ hình ảnh về Adam Miller, CEO của Centauri Health Solutions, nếu có trong bài gốc ]
Jim Quagliaroli, Managing Partner at Silversmith Capital Partners, also commented on Centauri’s impressive journey: “We are incredibly proud of Centauri’s remarkable growth since our initial investment in 2016. From a company of fewer than 100 employees to over 1,200 by the close of 2019, Centauri’s management team has consistently delivered exceptional value. We are excited to continue supporting the Company’s future growth alongside Abry Partners.” This testimonial from a previous investor further validates the strong growth trajectory that attracted Abry Partners.
Nick Scola, Partner at Abry Partners, articulated the firm’s investment rationale: “Centauri Health Solutions perfectly embodies Abry Partners’ ideal investment profile within the healthcare sector. Adam Miller and his leadership team have cultivated an outstanding organization that provides demonstrable economic benefits to payors, providers, and patients navigating an increasingly complex healthcare system. Abry Partners is eager to partner with Centauri’s leadership to fuel further expansion through ongoing investments in cutting-edge technology and top-tier talent, as well as through strategic mergers and acquisitions.” Scola’s statement clearly emphasizes Abry Partners’ strategic vision for Centauri and their commitment to long-term growth.
[ hình ảnh về Nick Scola, Partner tại Abry Partners, nếu có trong bài gốc ]
Michael Balmuth, Managing Partner at SV Health Investors, added his perspective on the successful partnership with Centauri: “Working with the Centauri team has been a privilege. They have exemplified the principle of ‘doing well by doing good,’ creating significant shareholder value while simultaneously improving patient care and fostering a thriving workplace for employees. We are delighted to support Centauri’s continued expansion in collaboration with management and our co-investors, including Abry Partners.”
The transaction, which is anticipated to close in Q1 2020, remains subject to standard closing conditions. Upon completion, Nick Scola, Chris Ritchie, and Joe Cammarosano from Abry Partners will join Centauri’s Board of Directors. They will sit alongside Jim Quagliaroli from Silversmith, Michael Balmuth from SV Health, and CEO Adam Miller, creating a robust and experienced board to guide Centauri’s future direction.
William Blair & Company LLC served as the exclusive financial advisor to Centauri, while Choate Hall & Stewart LLP and Weiss Brown LLP provided legal counsel. Abry Partners received legal counsel from Kirkland & Ellis LLP and financial advice from Robert W. Baird & Co.
About Abry Partners
Abry Partners is recognized as one of the most seasoned and successful sector-focused private equity firms operating in North America. Founded in 1989, Abry Partners has an impressive track record, having completed over $82.0 billion in leveraged transactions and other private equity and preferred equity placements. With a focus on building market-leading companies, Abry Partners currently manages over $5.0 billion in capital across its active funds. The firm’s deep sector expertise and operational resources make them a valuable partner for growth-oriented businesses like Centauri Health Solutions. Abry Partners distinguishes itself through a sector-specific approach, concentrating on industries where they have developed deep knowledge and a strong network, enabling them to identify and nurture high-potential companies.
About Centauri Health Solutions
Centauri Health Solutions is a prominent provider of technology-enabled services to payors and providers participating in government-sponsored healthcare programs, including Medicare Advantage and Medicaid. Centauri’s mission is to enhance the lives and health outcomes of members and patients through compassionate outreach, sophisticated data analytics, and innovative, data-driven solutions. The company’s services are specifically designed to address critical challenges within the healthcare system, such as uncompensated care, accurate risk-adjusted revenue for specialized populations, and comprehensive quality of care measurement. Headquartered in Scottsdale, Arizona, Centauri Health Solutions employs over 1,200 dedicated professionals across seven locations in the United States. Centauri’s rapid growth has been recognized by Inc. Magazine, ranking No. 132 on the 2019 Inc. 5000 list of the fastest-growing private companies in the U.S., a testament to their market impact and innovative approach.
About Silversmith Capital Partners
Established in 2015, Silversmith Capital Partners is a growth equity firm based in Boston, managing $1.1 billion in capital. Silversmith’s investment philosophy centers on partnering with and supporting exceptional entrepreneurs in rapidly growing and profitable technology and healthcare companies. The firm typically invests between $20 million and $100 million per company. Their portfolio includes notable companies such as ActiveCampaign, Digital Map Products, Impact, LifeStance Health, MediQuant, Nordic Consulting Partners, and Validity, in addition to Centauri Health Solutions. The partners at Silversmith bring over 75 years of combined investment experience and have served on the boards of numerous successful growth companies, demonstrating their expertise in guiding companies to scale and success.
About SV Health Investors
SV Health Investors, formerly known as SV Life Sciences, is a venture capital and growth equity firm specializing in the healthcare and life sciences sectors. SV Health Investors focuses on early-stage biotechnology opportunities, early-stage and revenue-stage medical device companies, and growth equity investments in later-stage healthcare services and digital health businesses. With a history spanning over 25 years, SV Health Investors has invested in more than 175 companies and currently manages over $2.9 billion in capital commitments across nine private venture capital funds and one publicly listed fund. SV Health Investors operates from offices in Boston and London, providing a transatlantic perspective on healthcare innovation and investment.
